E Fund Management Co., Ltd. Iveric Bio, Inc. Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$26.24 - $39.63 $162,583 - $245,547	-6,196 Reduced 34.59%	11,717 $461,000
Q1 2023 May 11, 2023	SELL	$18.67 - $24.56 $55,375 - $72,844	-2,966 Reduced 14.21%	17,913 $436,000
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $81,803 - $113,642	-4,745 Reduced 18.52%	20,879 $447,000
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $137,023 - $270,986	-14,577 Reduced 36.26%	25,624 $460,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $217,338 - $450,405	23,831 Added 145.58%	40,201 $387,000
Q1 2022 May 12, 2022	BUY	$12.15 - $16.83 $55,185 - $76,441	4,542 Added 38.4%	16,370 $276,000
Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $73,949 - $100,416	5,347 Added 82.5%	11,828 $198,000
Q1 2021 May 12, 2021	BUY	$5.08 - $6.89 $32,923 - $44,654	6,481 New	6,481 $40,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.